BR100 Increased By (0.08%)
BR30 Increased By (0.57%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.35 Increased By ▲ 0.03 (0.47%)
BECO 4.39 Increased By ▲ 0.12 (2.81%)
BML 62.50 Increased By ▲ 0.05 (0.08%)
BOP 31.47 Increased By ▲ 0.24 (0.77%)
CNERGY 11.70 Increased By ▲ 0.11 (0.95%)
CSIL 5.92 Increased By ▲ 0.20 (3.5%)
FCCL 61.60 Increased By ▲ 0.06 (0.1%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 6.33 Increased By ▲ 0.07 (1.12%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.79 Increased By ▲ 0.11 (0.45%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.05 Decreased By ▼ -2.23 (-1.27%)
NCPL 51.85 Decreased By ▼ -0.92 (-1.74%)
NPL 54.19 Increased By ▲ 0.07 (0.13%)
OGDC 315.50 Increased By ▲ 2.11 (0.67%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.51 Decreased By ▼ -0.29 (-0.81%)
PIBTL 13.65 Increased By ▲ 0.18 (1.34%)
PPL 226.60 Increased By ▲ 4.79 (2.16%)
PRL 80.30 Increased By ▲ 1.22 (1.54%)
PTC 46.89 Increased By ▲ 0.04 (0.09%)
SSGC 23.90 Increased By ▲ 0.03 (0.13%)
TBL 9.30 Decreased By ▼ -0.01 (-0.11%)
TELE 7.65 Increased By ▲ 0.26 (3.52%)
TPL 24.51 Decreased By ▼ -0.60 (-2.39%)
TPLP 13.04 Increased By ▲ 0.53 (4.24%)
TREET 26.05 Decreased By ▼ -0.20 (-0.76%)
TRG 53.38 Decreased By ▼ -0.06 (-0.11%)
World

Mexico to ramp up distribution of Sputnik V vaccine through March

  • Over the first three months of the year, more than 21 million total doses are expected from US drugmaker Pfizer Inc , China's CanSino Biologics Inc, Britain's AstraZeneca, and Sputnik V.
Published Updated
By

MEXICO CITY: Mexico aims to administer 7.4 million doses of Sputnik V, a Russian-developed COVID-19 vaccine, to its people by the end of March, part of the country's scramble to secure as much supply as quickly as possible.

The Mexican government has yet to approve the vaccine's use, an official plan showed on Tuesday.

The plan nonetheless expects 400,000 doses to arrive during the week ending Jan. 29.

The vaccine distribution plan was presented during President Andres Manuel Lopez Obrador's daily morning news conference as he seeks to promote the government's commitment to speedy delivery of four vaccines.

Over the first three months of the year, more than 21 million total doses are expected from US drugmaker Pfizer Inc , China's CanSino Biologics Inc, Britain's AstraZeneca, and Sputnik V.

Expected to be Mexico's most-used vaccine during that time, Sputnik V requires two doses per person, and if the official schedule is met, 3.7 million people will have been inoculated with it by the end of March, the figures showed.

Government officials say Mexico is set to purchase 12 million doses of the Russian vaccine, and that health authorities could approve its use in the country very soon.

Comments

Comments are closed for this article.